(ITRI) Itron - Overview
Sector: Technology | Industry: Scientific & Technical Instruments | Exchange: NASDAQ (USA) | Market Cap: 3.681m USD | Total Return: -27.5% in 12m
Avg Turnover: 57.6M
EPS Trend: 94.1%
Qual. Beats: 2
Rev. Trend: 76.5%
Qual. Beats: 2
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Itron, Inc. (ITRI) is a technology provider specializing in energy, water, and smart city infrastructure management. The company operates through four distinct segments: Device Solutions, Networked Solutions, Outcomes, and Resiliency Solutions. Its portfolio ranges from physical hardware like smart meters and sensors to advanced software platforms utilizing artificial intelligence and machine learning for data analytics and grid optimization.
The business model relies on the ongoing transition toward Advanced Metering Infrastructure (AMI), which allows utilities to move from simple data collection to two-way communication and real-time grid management. As a provider in the Electronic Equipment & Instruments sector, Itron benefits from global municipal investments in smart city initiatives aimed at reducing resource waste and improving utility resilience. The company serves a diverse global client base through direct sales, distributors, and strategic partnerships.
For a deeper look into the companys valuation metrics and historical performance, consider reviewing the comprehensive data available on ValueRay.
- Utility grid modernization projects drive demand for advanced networked metering infrastructure
- Transition to high-margin software and services outcomes improves consolidated EBITDA margins
- Supply chain stability and component availability dictate quarterly hardware delivery volumes
- Federal infrastructure spending and smart city initiatives accelerate municipal contract awards
- Rising global water scarcity increases adoption of digital leak detection and management systems
| Net Income: 289.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.39 > 1.0 |
| NWC/Revenue: 40.52% < 20% (prev 37.60%; Δ 2.92% < -1%) |
| CFO/TA 0.10 > 3% & CFO 417.3m > Net Income 289.0m |
| Net Debt (1.35b) to EBITDA (409.4m): 3.29 < 3 |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (45.5m) vs 12m ago -1.52% < -2% |
| Gross Margin: 38.82% > 18% (prev 0.35%; Δ 3.85k% > 0.5%) |
| Asset Turnover: 62.74% > 50% (prev 69.78%; Δ -7.04% > 0%) |
| Interest Coverage Ratio: 13.47 > 6 (EBITDA TTM 409.4m / Interest Expense TTM 26.2m) |
| A: 0.24 (Total Current Assets 1.52b - Total Current Liabilities 573.6m) / Total Assets 3.98b |
| B: 0.04 (Retained Earnings 165.2m / Total Assets 3.98b) |
| C: 0.09 (EBIT TTM 353.4m / Avg Total Assets 3.74b) |
| D: 0.68 (Book Value of Equity 1.61b / Total Liabilities 2.35b) |
| Altman-Z'' = 3.06 = A |
| DSRI: 1.18 (Receivables 393.2m/346.6m, Revenue 2.35b/2.44b) |
| GMI: 0.90 (GM 38.82% / 34.82%) |
| AQI: 1.38 (AQ_t 0.58 / AQ_t-1 0.42) |
| SGI: 0.96 (Revenue 2.35b / 2.44b) |
| TATA: -0.03 (NI 289.0m - CFO 417.3m) / TA 3.98b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of May 31, 2026, the stock is trading at USD 82.48 with a total of 759,410 shares traded.
Over the past week, the price has changed by +0.77%,
over one month by -0.25%,
over three months by -12.21% and
over the past year by -27.46%.
Itron has received a consensus analysts rating of 4.23. Therefore, it is recommended to buy ITRI.
- StrongBuy: 7
- Buy: 3
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 126.7 | 53.6% |
P/E Trailing = 13.262
P/E Forward = 13.8889
P/S = 1.5684
P/B = 2.258
P/EG = 0.7314
Revenue TTM = 2.35b USD
EBIT TTM = 353.4m USD
EBITDA TTM = 409.4m USD
Long Term Debt = 1.57b USD (from longTermDebt, last quarter)
Short Term Debt = 459.5m USD (from shortTermDebt, last fiscal year)
Debt = 2.06b USD (corrected: LT Debt 1.57b + ST Debt 459.5m) + Leases 28.3m
Net Debt = 1.35b USD (calculated: Debt 2.06b - CCE 712.9m)
Enterprise Value = 5.03b USD (3.68b + Debt 2.06b - CCE 712.9m)
Interest Coverage Ratio = 13.47 (Ebit TTM 353.4m / Interest Expense TTM 26.2m)
EV/FCF = 12.81x (Enterprise Value 5.03b / FCF TTM 392.5m)
FCF Yield = 7.80% (FCF TTM 392.5m / Enterprise Value 5.03b)
FCF Margin = 16.72% (FCF TTM 392.5m / Revenue TTM 2.35b)
Net Margin = 12.32% (Net Income TTM 289.0m / Revenue TTM 2.35b)
Gross Margin = 38.82% ((Revenue TTM 2.35b - Cost of Revenue TTM 1.44b) / Revenue TTM)
Gross Margin QoQ = 40.26% (prev 40.54%)
Tobins Q-Ratio = 1.26 (Enterprise Value 5.03b / Total Assets 3.98b)
Interest Expense / Debt = 1.27% (Interest Expense 26.2m / Debt 2.06b)
Taxrate = 20.25% (13.6m / 67.2m)
NOPAT = 281.9m (EBIT 353.4m * (1 - 20.25%))
Current Ratio = 2.66 (Total Current Assets 1.52b / Total Current Liabilities 573.6m)
Debt / Equity = 1.28 (Debt 2.06b / totalStockholderEquity, last quarter 1.61b)
Debt / EBITDA = 3.29 (Net Debt 1.35b / EBITDA 409.4m)
Debt / FCF = 3.44 (Net Debt 1.35b / FCF TTM 392.5m)
Total Stockholder Equity = 1.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.73% (Net Income 289.0m / Total Assets 3.98b)
RoE = 17.44% (Net Income TTM 289.0m / Total Stockholder Equity 1.66b)
RoCE = 10.94% (EBIT 353.4m / Capital Employed (Equity 1.66b + L.T.Debt 1.57b))
RoIC = 7.32% (NOPAT 281.9m / Invested Capital 3.85b)
WACC = 6.50% (E(3.68b)/V(5.74b) * Re(9.57%) + D(2.06b)/V(5.74b) * Rd(1.27%) * (1-Tc(0.20)))
Discount Rate = 9.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -2.22 | Cagr: -0.55%
[DCF] Terminal Value 77.97% ; FCFF base≈340.3m ; Y1≈390.1m ; Y5≈574.1m
[DCF] Fair Price = 164.4 (EV 8.64b - Net Debt 1.35b = Equity 7.29b / Shares 44.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 94.11 | EPS CAGR: 49.37% | SUE: 1.42 | # QB: 2
Revenue Correlation: 76.46 | Revenue CAGR: 6.66% | SUE: 1.57 | # QB: 2
EPS current Quarter (2026-06-30): EPS=1.29 | Chg30d=-12.75% | Revisions=-67% | Analysts=11
EPS next Quarter (2026-09-30): EPS=1.56 | Chg30d=-4.56% | Revisions=-64% | Analysts=11
EPS current Year (2026-12-31): EPS=5.97 | Chg30d=-1.30% | Revisions=-17% | GrowthEPS=-16.2% | GrowthRev=+0.9%
EPS next Year (2027-12-31): EPS=6.61 | Chg30d=-3.94% | Revisions=-33% | GrowthEPS=+10.7% | GrowthRev=+6.5%
[Analyst] Revisions Ratio: -67%